Corporate Board Profile
Tech Score: 33/100
1 mention(s) identify DR. RAMKUMAR MANDALAM, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Cryoport, Inc. | 2018-04-09 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Dr. Mandalam is the author or co-author of several publications, patent applications, and abstracts. Dr. Mandalam’s business and management expertise, accomplishments as a scientist, extensive background in biotechnology and makes him well-qualified to serve as a member of the board of directors. | Dr. Mandalam has a Ph.D. in Chemical Engineering and extensive experience in biotechnology and product development, indicating strong technical and scientific skills that likely include programming or related technical expertise. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-09-02 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Dr. Mandalam is the author or co-author of several publications, patent applications, and abstracts. Dr. Mandalam’s training as a scientist, extensive background in biotechnology and management expertise and makes him well qualified to serve as a member of the board of directors. |
| 2017-08-11 | Dr. Mandalam is the President and CEO of Cellerant Therapeutics, Inc., a biotechnology company. He received his Ph.D. in Chemical Engineering from the University of Michigan. No mention of computer science or programming. |
| 2018-04-09 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Dr. Mandalam is the author or co-author of several publications, patent applications, and abstracts. Dr. Mandalam’s business and management expertise, accomplishments as a scientist, extensive background in biotechnology and makes him well-qualified to serve as a member of the board of directors. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22